ArticleMaterials today. Bio2026
Bio-inspired polyphenol-polyelectrolyte WRAP system for geometrically controlled AAV delivery in diverse anatomical sites.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic delivery of therapeutics frequently requires elevated dosing to achieve effective local concentrations, often resulting in unintended toxicity and insufficient drug levels at the target site. To address this inherent limitation, localized drug and gene delivery strategies have been developed to deposit therapeutic payloads directly within diseased microenvironments. Herein, we report the development of a WRAP (Writable, Retentive, Adhesive, Permeable) drug delivery scaffold system, a biomaterial-mediated polyelectrolyte complex (PEC) film formed through spontaneous ionic complexation between chitosan and alginate. These naturally derived polymers form stable electrostatic interactions through their complementary charged groups, resulting in tunable film properties that maximize local therapeutic concentrations while minimizing adverse events during systemic exposure to therapeutics. To strengthen adhesion and sustain retention on wet tissue surfaces, chitosan-gallol (Chi-G) was incorporated as the cationic component of the PEC film, providing gallol-mediated surface binding and controlled loading of diverse therapeutic agents. When applied to adeno-associated virus (AAV), WRAP facilitated
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.